When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TAK - Cardiff Oncology: Can They Succeed Where Others Have Failed?
Takeda Pharmaceutical Company Limited American Depositary Shares
Cardiff Oncology is a single-asset company focused on developing a PLK1 inhibitor called onvansertib.
PLK1 inhibitors have a poor history in the clinic, but Cardiff believes their patient-targeted approach and therapeutic combination regime can overcome past failures.
Previously released results were impressive, but recent updates have put a damper on some of the earlier results.